Viemed Healthcare Inc 2025年度报告

Form 10-K TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934 Commission file number: 001-38973 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) N/A(IRS EmployerIdentification Number) British Columbia, Canada(State or other jurisdiction ofincorporation or organization) 625 E. Kaliste Saloom Rd.Lafayette, LA 70508(Address of principal executive offices, including zip code) (337) 504-3802(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: The Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities ActYes☐No☒ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the ActYes☐No☒ Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of theSecurities Exchange Act of 1934 during the preceding 12months (or for such shorter period that the registrant was requiredto file such reports), and (2)has been subject to such filing requirements for the past 90days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule405 of RegulationS-T (§232.405 of this chapter) during the preceding 12months (or for suchshorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition periodfor complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of theeffectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to§240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the ExchangeAct).Yes☐No☒ The aggregate market value of the voting and non-voting common shares held by non-affiliates of the registrant computed asof June 30, 2025 (the last business day of the registrant’s most recent completed second fiscal quarter) based on the closingprice of the common shares on the Nasdaq Stock Market LLC was $238,786,569. As of February20, 2026, there were 38,602,631 common shares of the registrant outstanding. DOCUMENTS INCORPORATED BY REFERENCE Certain information required to be disclosed in Part III of this report is incorporated by reference from the registrant’s definitiveproxy statement or an amendment to this report, which will be filed with the SEC not later than 120 days after the end of thefiscal year covered by this report. PagePART I5Item 1. Business5Item 1A. Risk Factors14Item 1B. Unresolved Staff Comments27Item 1C. Cybersecurity27Item 2. Properties28Item 3. Legal Proceedings28Item 4. Mine Safety Disclosures28PART II29Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities29Item 6. Reserved30Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations31Item 7A. Quantitative and Qualitative Disclosures About Market Risk42Item 8. Financial Statements and Supplementary DataF-1Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure44Item 9A. Controls and Procedures44Item 9B. Other Information47Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections47PART III48Item 10. Directors, Executive Officers and Corporate Governance48Item 11. Executive Compensation48Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters48Item 13. Certain Relationships and Related Transactions, and Director Independence48Item 14. Principal Accounta